In the light of previous data showing that FGF-21 may be useful in a subgroup of patients with mitochondrial disease [5], in 2013 we adopted measurement of FGF-21 as an adjunct to first-line routine laboratory tests. Here, FGF21 is linked to inborn mitochondrial metabolism disorder.